US Stock MarketDetailed Quotes

RGC Regencell Bioscience

Watchlist
  • 4.920
  • -0.310-5.93%
Close Dec 20 16:00 ET
64.02MMarket Cap-14.91P/E (TTM)

About Regencell Bioscience Company

Regencell Bioscience Holdings Ltd. engages in the research, development, and commercialization of traditional Chinese medicine. It seeks the treatment of neurocognitive disorders and degeneration, specifically attention deficit hyperactivity disorder and autism spectrum disorder. The company was founded by Yat-Gai Au on October 30, 2014 and is headquartered in Hong Kong.

Company Profile

SymbolRGC
Company NameRegencell Bioscience
Listing DateJul 16, 2021
Issue Price9.50
Founded2014
CEOMr. Yat-Gai Au
MarketNASDAQ
Employees12
Fiscal Year Ends06-30
Address9/F, Chinachem Leighton Plaza, 29 Leighton Road, Causeway Bay, Hong Kong
CityHong Kong,China
ProvinceHK
CountryChina
Phone852-2155-0823

Company Executives

  • Name
  • Position
  • Salary
  • Yat-Gai Au
  • Chief Executive Officer and Chairman of the Board
  • --
  • Yat-Pui Au
  • Chief Business Officer; Senior Vice President, Regencell Bioscience Limited
  • --
  • Wai Hong James Chung
  • Director, Chief Operating Officer and Chief Strategy Officer; Vice President, Regencell Bioscience Limited
  • --
  • Yee Wah Evana Hui
  • Independent Director
  • --
  • Paul J. Niewiadoi
  • Independent Director
  • --
  • Dr. Wing Yan William Lo
  • Independent Director
  • --
Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries

Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.